Century Therapeutics, Inc.

NASDAQ:IPSC

0.55 (USD) • At close May 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -126.566-136.673-130.932-95.824-53.575-244.769
Depreciation & Amortization 13.30413.0448.443.7481.4020.249
Deferred Income Tax 0.870004.7220
Stock Based Compensation 12.68814.62210.6694.6620.8760.147
Change In Working Capital -9.2789.38123.945-2.7974.8622.259
Accounts Receivables 000000
Inventory 000000
Accounts Payables -1.469-2.361-4.788-1.8482.0621.233
Other Working Capital -7.80911.741128.733-0.9492.81.026
Other Non Cash Items -1.15311.2791.931.2090.444225.946
Operating Cash Flow -110.135-88.34814.052-89.002-41.269-16.168
Investing Activities:
Investments In Property Plant And Equipment 0-13.736-30.604-44.97-9.825-2.46
Acquisitions Net -9.6080-238.218-30.336-4.72224.166
Purchases Of Investments 0-209.034-254-330.034-49.86-41.54
Sales Maturities Of Investments 176.792283.902271.47676.66641.65-24.166
Other Investing Activites -119.7020238.21830.336-4.72224.166
Investing Cash Flow 47.48261.132-13.128-298.338-22.757-19.834
Financing Activities:
Debt Repayment 0-10.241009.7340
Common Stock Issued 74.5630.51627.158221.61538.174.839
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 74.56300196.15937.95674.839
Financing Cash Flow 74.563-9.72527.158417.77447.6974.839
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 11.91-36.94128.08230.434-16.33638.837
Cash At End Of Period 61.21349.30386.24458.16227.72870.261